CONMED CORPORATION Operating Expenses
CONMED CORPORATION (CNMD) reported Operating Expenses of $161.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-29
- CONMED CORPORATION operating expenses for the quarter ending 2026-06-30 was $161.05M, a 7.25% increase year-over-year.
- CONMED CORPORATION operating expenses for the quarter ending 2025-12-31 was $181.66M, a 24.56% increase year-over-year.
- CONMED CORPORATION operating expenses for the quarter ending 2025-09-30 was $154.24M, a 36.15% increase year-over-year.
- CONMED CORPORATION operating expenses for the quarter ending 2025-06-30 was $150.16M, a 9.91% increase year-over-year.
- CONMED CORPORATION operating expenses for fiscal 2025 was $647.85M, a 21.62% increase from fiscal 2024.
- CONMED CORPORATION operating expenses for fiscal 2024 was $532.71M, a 4.13% decline from fiscal 2023.
- CONMED CORPORATION operating expenses for fiscal 2023 was $555.64M, a 10.86% increase from fiscal 2022.
- CONMED CORPORATION operating expenses for fiscal 2022 was $501.19M, a 9.35% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $161.05M 10-Q · filed 2026-07-29 | $319.08M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $181.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $335.90M derived: sum of 2 quarters · filed 2026-02-17 | $486.06M derived: sum of 3 quarters · filed 2026-07-29 | $647.85M 10-K · filed 2026-02-17 |
| 2025-09-30 | $154.24M 10-Q · filed 2025-11-06 | $304.40M derived: sum of 2 quarters · filed 2026-07-29 | $466.19M 10-Q · filed 2025-11-06 | $612.04M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $150.16M 10-Q · filed 2026-07-29 | $311.95M 10-Q · filed 2026-07-29 | $457.80M derived: sum of 3 quarters · filed 2026-07-29 | $571.09M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $161.79M 10-Q · filed 2025-05-01 | $307.64M derived: sum of 2 quarters · filed 2026-02-17 | $420.93M derived: sum of 3 quarters · filed 2026-02-17 | $557.55M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $145.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $259.13M derived: sum of 2 quarters · filed 2026-02-17 | $395.75M derived: sum of 3 quarters · filed 2026-02-17 | $532.71M 10-K · filed 2026-02-17 |
| 2024-09-30 | $113.29M 10-Q · filed 2025-11-06 | $249.91M derived: sum of 2 quarters · filed 2025-11-06 | $386.86M 10-Q · filed 2025-11-06 | $518.85M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $136.62M 10-Q · filed 2025-07-31 | $273.57M 10-Q · filed 2025-07-31 | $405.56M derived: sum of 3 quarters · filed 2026-02-17 | $543.32M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $136.95M 10-Q · filed 2025-05-01 | $268.94M derived: sum of 2 quarters · filed 2026-02-17 | $406.70M derived: sum of 3 quarters · filed 2026-02-17 | $549.97M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $131.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $269.75M derived: sum of 2 quarters · filed 2026-02-17 | $413.02M derived: sum of 3 quarters · filed 2026-02-17 | $555.64M 10-K · filed 2026-02-17 |
| 2023-09-30 | $137.76M 10-Q · filed 2024-10-31 | $281.03M derived: sum of 2 quarters · filed 2024-10-31 | $423.65M 10-Q · filed 2024-10-31 | $556.61M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $143.27M 10-Q · filed 2024-08-01 | $285.89M 10-Q · filed 2024-08-01 | $418.85M derived: sum of 3 quarters · filed 2025-02-18 | $546.22M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $142.62M 10-Q · filed 2024-04-25 | $275.58M derived: sum of 2 quarters · filed 2025-02-18 | $402.95M derived: sum of 3 quarters · filed 2025-02-18 | $530.26M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $132.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $260.32M derived: sum of 2 quarters · filed 2025-02-18 | $387.64M derived: sum of 3 quarters · filed 2025-02-18 | $501.19M 10-K · filed 2025-02-18 |
| 2022-09-30 | $127.37M 10-Q · filed 2023-10-26 | $254.69M derived: sum of 2 quarters · filed 2023-10-26 | $368.23M 10-Q · filed 2023-10-26 | $486.87M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $127.32M 10-Q · filed 2023-07-27 | $240.87M 10-Q · filed 2023-07-27 | $359.51M derived: sum of 3 quarters · filed 2024-02-28 | $475.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $113.55M 10-Q · filed 2023-04-27 | $232.19M derived: sum of 2 quarters · filed 2024-02-28 | $347.78M derived: sum of 3 quarters · filed 2024-02-28 | $463.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $118.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $234.24M derived: sum of 2 quarters · filed 2024-02-28 | $349.95M derived: sum of 3 quarters · filed 2024-02-28 | $458.32M 10-K · filed 2024-02-28 |
| 2021-09-30 | $115.59M 10-Q · filed 2022-10-27 | $231.31M derived: sum of 2 quarters · filed 2022-10-27 | $339.68M 10-Q · filed 2022-10-27 | $450.49M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $115.72M 10-Q · filed 2022-07-28 | $224.08M 10-Q · filed 2022-07-28 | $334.90M derived: sum of 3 quarters · filed 2023-02-21 | $439.21M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $108.37M 10-Q · filed 2022-05-05 | $219.18M derived: sum of 2 quarters · filed 2023-02-21 | $323.50M derived: sum of 3 quarters · filed 2023-02-21 | $416.67M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $110.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $215.13M derived: sum of 2 quarters · filed 2023-02-21 | $308.30M derived: sum of 3 quarters · filed 2023-02-21 | $414.29M 10-K · filed 2023-02-21 |
| 2020-09-30 | $104.32M 10-Q · filed 2021-10-28 | $197.49M derived: sum of 2 quarters · filed 2021-10-28 | $303.48M 10-Q · filed 2021-10-28 | $417.57M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $93.17M 10-Q · filed 2021-07-29 | $199.16M 10-Q · filed 2021-07-29 | $313.26M derived: sum of 3 quarters · filed 2022-02-22 | $422.43M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $105.99M 10-Q · filed 2021-04-29 | $220.08M derived: sum of 2 quarters · filed 2022-02-22 | $329.25M derived: sum of 3 quarters · filed 2022-02-22 | $441.79M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $114.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $223.27M derived: sum of 2 quarters · filed 2022-02-22 | $335.80M derived: sum of 3 quarters · filed 2022-02-22 | $445.60M 10-K · filed 2022-02-22 |
| 2019-09-30 | $109.17M 10-Q · filed 2020-10-29 | $221.70M derived: sum of 2 quarters · filed 2020-10-29 | $331.51M 10-Q · filed 2020-10-29 | $438.34M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $112.53M 10-Q · filed 2020-07-30 | $222.33M 10-Q · filed 2020-07-30 | $329.17M derived: sum of 3 quarters · filed 2021-02-22 | $428.27M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $109.80M 10-Q · filed 2020-04-30 | $216.63M derived: sum of 2 quarters · filed 2021-02-22 | $315.74M derived: sum of 3 quarters · filed 2021-02-22 | $415.33M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $106.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $205.94M derived: sum of 2 quarters · filed 2021-02-22 | $305.53M derived: sum of 3 quarters · filed 2021-02-22 | $397.81M 10-K · filed 2021-02-22 |
| 2018-09-30 | $99.11M 10-Q · filed 2019-10-31 | $198.69M derived: sum of 2 quarters · filed 2019-10-31 | $290.97M 10-Q · filed 2019-10-31 | $391.75M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $99.59M 10-Q · filed 2019-08-01 | $191.87M 10-Q · filed 2019-08-01 | $292.65M derived: sum of 3 quarters · filed 2020-02-24 | $381.73M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $92.28M 10-Q · filed 2019-04-26 | $193.06M derived: sum of 2 quarters · filed 2020-02-24 | $282.14M derived: sum of 3 quarters · filed 2020-02-24 | $374.01M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $100.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $189.86M derived: sum of 2 quarters · filed 2020-02-24 | $281.73M derived: sum of 3 quarters · filed 2020-02-24 | $384.11M 10-K · filed 2020-02-24 |
| 2017-09-30 | $89.08M 10-Q · filed 2018-11-02 | $180.95M derived: sum of 2 quarters · filed 2018-11-02 | $283.32M 10-Q · filed 2018-11-02 | $377.68M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $91.87M 10-Q · filed 2018-08-02 | $194.25M 10-Q · filed 2018-08-02 | $288.60M derived: sum of 3 quarters · filed 2019-02-25 | $375.96M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $102.38M 10-Q · filed 2018-04-26 | $196.73M derived: sum of 2 quarters · filed 2019-02-25 | $284.09M derived: sum of 3 quarters · filed 2019-02-25 | $378.83M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $94.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $181.72M derived: sum of 2 quarters · filed 2019-02-25 | $276.45M derived: sum of 3 quarters · filed 2019-02-25 | $370.65M 10-K · filed 2019-02-25 |
| 2016-09-30 | $87.36M 10-Q · filed 2017-11-02 | $182.10M derived: sum of 2 quarters · filed 2017-11-02 | $276.30M 10-Q · filed 2017-11-02 | $365.71M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $94.74M 10-Q · filed 2017-07-27 | $188.94M 10-Q · filed 2017-07-27 | $278.35M derived: sum of 3 quarters · filed 2018-02-26 | $357.06M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $94.20M 10-Q · filed 2017-04-27 | $183.61M derived: sum of 2 quarters · filed 2018-02-26 | $262.32M derived: sum of 3 quarters · filed 2018-02-26 | $343.40M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $89.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $168.12M derived: sum of 2 quarters · filed 2018-02-26 | $249.20M derived: sum of 3 quarters · filed 2018-02-26 | $330.53M 10-K · filed 2018-02-26 |
| 2015-09-30 | $78.71M 10-Q · filed 2016-10-28 | $159.79M derived: sum of 2 quarters · filed 2016-10-28 | $241.12M 10-Q · filed 2016-10-28 | $328.06M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $81.08M 10-Q · filed 2016-07-28 | $162.41M 10-Q · filed 2016-07-28 | $249.35M derived: sum of 3 quarters · filed 2017-02-27 | $343.32M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $81.33M 10-Q · filed 2016-05-02 | $168.27M derived: sum of 2 quarters · filed 2017-02-27 | $262.24M derived: sum of 3 quarters · filed 2017-02-27 | $347.32M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $86.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $180.91M derived: sum of 2 quarters · filed 2017-02-27 | $266.00M derived: sum of 3 quarters · filed 2017-02-27 | $351.27M 10-K · filed 2017-02-27 |
| 2014-09-30 | $93.97M 10-Q · filed 2015-10-23 | $179.05M derived: sum of 2 quarters · filed 2015-10-23 | $264.33M 10-Q · filed 2015-10-23 | $359.54M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $85.09M 10-Q · filed 2015-07-27 | $170.36M 10-Q · filed 2015-07-27 | $265.58M derived: sum of 3 quarters · filed 2016-02-23 | $352.19M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $85.27M 10-Q · filed 2015-04-24 | $180.49M derived: sum of 2 quarters · filed 2016-02-23 | $267.11M derived: sum of 3 quarters · filed 2016-02-23 | $354.37M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $95.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $181.83M derived: sum of 2 quarters · filed 2016-02-23 | $269.10M derived: sum of 3 quarters · filed 2016-02-23 | $355.91M 10-K · filed 2016-02-23 |
| 2013-09-30 | $86.62M 10-Q · filed 2014-10-24 | $173.88M derived: sum of 2 quarters · filed 2014-10-24 | $260.69M 10-Q · filed 2014-10-24 | $350.97M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $87.26M 10-Q · filed 2014-07-25 | $174.08M 10-Q · filed 2014-07-25 | $264.35M derived: sum of 3 quarters · filed 2015-02-23 | $348.15M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $86.81M 10-Q · filed 2014-04-25 | $177.08M derived: sum of 2 quarters · filed 2015-02-23 | $260.88M derived: sum of 3 quarters · filed 2015-02-23 | $343.56M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $90.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $174.07M derived: sum of 2 quarters · filed 2015-02-23 | $256.74M derived: sum of 3 quarters · filed 2015-02-23 | $340.63M 10-K · filed 2015-02-23 |
| 2012-09-30 | $83.80M 10-Q · filed 2013-10-28 | $166.47M derived: sum of 2 quarters · filed 2013-10-28 | $250.36M 10-Q · filed 2013-10-28 | $388.44M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $82.67M 10-Q · filed 2013-07-29 | $166.56M 10-Q · filed 2013-07-29 | $304.64M derived: sum of 3 quarters · filed 2014-02-24 | $380.01M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $83.89M 10-Q · filed 2013-04-29 | $221.97M derived: sum of 2 quarters · filed 2014-02-24 | $297.34M derived: sum of 3 quarters · filed 2014-02-24 | $372.10M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $138.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $213.45M derived: sum of 2 quarters · filed 2014-02-24 | $288.21M derived: sum of 3 quarters · filed 2014-02-24 | $366.66M 10-K · filed 2014-02-24 |
| 2011-09-30 | $75.37M 10-Q · filed 2012-10-29 | $150.13M derived: sum of 2 quarters · filed 2012-10-29 | $228.58M 10-Q · filed 2012-10-29 | $305.95M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $74.76M 10-Q · filed 2012-07-30 | $153.21M 10-Q · filed 2012-07-30 | $230.58M derived: sum of 3 quarters · filed 2013-02-25 | $304.36M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $78.45M 10-Q · filed 2012-05-01 | $155.82M derived: sum of 2 quarters · filed 2013-02-25 | $229.60M derived: sum of 3 quarters · filed 2013-02-25 | $308.51M derived: sum of 4 quarters · filed 2013-02-25 |
| 2010-12-31 | $77.37M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $151.15M derived: sum of 2 quarters · filed 2013-02-25 | $230.06M derived: sum of 3 quarters · filed 2013-02-25 | $308.29M 10-K · filed 2013-02-25 |
| 2010-09-30 | $73.78M 10-Q · filed 2011-11-01 | $152.69M derived: sum of 2 quarters · filed 2011-11-01 | $230.92M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $78.91M 10-Q · filed 2011-08-09 | $157.14M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $309.06M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |